Aspen RxHealth

Overview

Aspen RxHealth is a clinical pharmacy services and medication-therapy-management platform that connects organizations with a distributed pharmacist community for remote patient consultations. For pharma teams, the relevant use case is pharmacist-led education, adherence support, medication monitoring, and long-term patient engagement for manufacturer programs.

The company is owned by MedImpact Healthcare Systems, which makes Aspen a PBM-adjacent diligence case. Buyers should evaluate Aspen as the operating service being bought: remote pharmacist engagement and clinical consultation infrastructure, not a PBM profile or specialty pharmacy.

Engagement & Adherence Capability Model

The framework below standardizes how Rx Almanac evaluates patient-engagement-adherence capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Aspen RxHealth is evaluated as clinical pharmacy services and medication-therapy-management platform that connects organizations with a distributed pharmacist community for remote patient consultations.

Capability	Buyer should compare	Aspen RxHealth readout
Behavioral segmentation and journey design	Patient segmentation, barrier identification, journey mapping, personalization rules, and intervention timing.	Not the main buying reason for Aspen RxHealth; validate only if the SOW includes behavioral segmentation and journey design.
Omnichannel patient communications	SMS, email, web, app, phone, print, and caregiver / HCP communications with consent management.	Core. Aspen uses remote pharmacist consultations and platform-enabled outreach rather than a hub call-center model.
Adherence coaching and persistence analytics	Refill reminders, adherence risk scoring, persistence tracking, motivational support, and outcomes measurement.	Core. The life-sciences page positions Aspen around medication education, monitoring, and long-term adherence.
Care-team escalation and human support	Nurse, coach, call-center, or case-manager escalation when digital nudges are insufficient.	Validate in RFP. Confirm manufacturer-specific escalation workflows and documentation.
Education content and program measurement	Disease education, onboarding content, MLR-ready materials, survey instruments, and performance reporting.	Core differentiator. Pharmacist credibility is the main reason to consider Aspen.
Hub, pharmacy, and CRM integration	Data exchange with hubs, specialty pharmacies, CRM, EHR, claims, and manufacturer reporting environments.	Validate in RFP. Buyers should request sample reports, data dictionaries, and quality-review outputs. Overlay. Aspen is not a specialty pharmacy, copay administrator, or full hub.

Buyer Fit

• Best shortlist motion: Include Aspen when pharmacist-led education, adherence support, and medication-therapy management are central to the program.
• Best-fit buyers: Life-sciences, patient-services, brand, health-plan, provider, PBM, and strategic-partner teams with specialty, chronic, or complex medication programs that need remote clinical consultation capacity.
• Less ideal fit: Programs that need benefit investigation, copay administration, dispensing, or human case-management as the primary scope.
• Commercial fit: Scope should define outreach ownership, pharmacist staffing, data returns, consent, escalation rules, and MedImpact/PBM separation.
• Therapeutic fit: Specialty and chronic therapies where education, side-effect monitoring, immunization, condition management, or regimen commitment affect outcomes and persistence.
• Implementation fit: Determine whether Aspen owns patient outreach, supplies pharmacist capacity, provides technology/reporting infrastructure, or operates alongside a hub, CRM, agency, and specialty pharmacy.

Differentiators

• Pharmacist network model: Aspen’s main distinction is distributed pharmacist consultation capacity rather than generic engagement software.
• Medication-therapy orientation: The model is strongest when medication education and regimen support are the intervention.
• Life-sciences positioning: Aspen has a dedicated manufacturer-facing page, which makes the profile relevant beyond payer MTM.
• Alliance platform infrastructure: Alliance by Aspen RxHealth extends the model into clinical pharmacy services capacity, patient matching, telephony, eligibility, documentation, and quality reporting workflows.
• PBM-adjacent ownership: MedImpact ownership creates both infrastructure adjacency and channel-conflict diligence questions.

RFP Questions

• Which patient populations, therapies, and outreach channels are live for life-sciences programs?
• How are pharmacist licensure, training, quality review, and therapy-specific scripts governed?
• What consent, HIPAA, adverse-event, product-complaint, and patient opt-out controls apply?
• Which data fields and outcome measures are returned to the manufacturer or hub partner?
• How are patient matching, channel preferences, multilingual support, eligibility queues, and documentation workflows configured?
• What manufacturer references can Aspen provide for branded, unbranded, specialty, or chronic-medication engagement programs?
• How does Aspen separate manufacturer work from MedImpact or payer-adjacent incentives?

Recent Activity

• 2023-11: Oregon transaction materials identified Aspen Health, Inc. as part of MedImpact’s acquisition structure.
• 2022-10: Aspen launched Alliance by Aspen RxHealth for clinical pharmacy services capacity and platform support.

See Also

• Medisafe — Digital companion and medication-management platform for pharma-sponsored engagement
• Momentum Life Sciences — Nurse-led patient engagement overlay
• Atlantis Health — Behavioral science patient engagement agency
• Cencora Patient Support Services (Lash Group) — Full-service hub and patient support operator